| 2915.39.70 | 00 | Isobutyl acetate | kg | 5.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 2.8% (SG) | 40% |
| 2915.39.80 | 00 | 2-Ethoxyethyl acetate (Ethylene glycol, monoethyl ether acetate) | kg | 5.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 54.5% |
| 2915.40 | | Mono-, di- or trichloroacetic acids, their salts and esters: | | | | |
| 2915.40.10 | 00 | Chloroacetic acids | kg | 1.8% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 17.5% |
| 2915.40.50 | 10 | Sodium chloroacetate | kg | | | |
| 2916.34 | | Phenylacetic acid and its salts: | | | | |
| 2916.34.10 | 00 | Phenylacetic acid ( α-Toluic acid) | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¡é/kg + 40.5% |
| 2916.35 | | Esters of phenylacetic acid: | | | | |
| 2916.39.17 | 00 | 2,2-Dichlorophenylacetic acid, ethyl ester; and m-Toluic acid | kg | Free | | 15.4¡é/kg + 57% |
| 2918.22 | | O-Acetylsalicylic acid, its salts and esters: | | | | |
| 2918.22.10 | 00 | O-Acetylsalicylic acid (Aspirin) | kg | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 82% |
| 2918.22.50 | 00 | Salts and esters of O-acetylsalicylic acid | kg | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4¡é/kg + 47.5% |
| 2918.30.10 | 00 | 1-Formylphenylacetic acid, methyl ester | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¡é/kg + 40% |
| 2918.30.70 | 00 | Dimethyl acetyl succinate; Oxalacetic acid diethyl ester, sodium salt; 4,4,4-Trifluoro-3-oxobutanoic acid, ethyl ester; and 4,4,4-Trifluoro-3-oxobutanoic acid, methyl ester | kg | Free | | 25% |
| 2918.91.00 | 00 | 2,4,5-T (ISO) (2,4,5-trichlorophenoxyacetic acid, its salts and esters | kg | 6.5% | Free (A,BH,CA, CL,E,IL,J,JO, MA,MX,P) 2.1% (AU) 2.9% (SG) | 15.4¡é/kg + 48.5% |
| 2918.99.18 | 00 | 4-(4-Chloro-2-methylphenoxy)butyric acid; p-Chlorophenoxyacetic acid; and 2-(2,4-Dichlorophenoxy)propionic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 40.5% |
| 2918.99.20 | 10 | 2,4-Dichlorophenoxyacetic acid, its salts and esters | kg | | | |
| 2918.99.20 | 15 | 2-Methyl-4-chlorophenoxyacetic acid | kg | | | |
| 2922.39.10 | 00 | 2'-Aminoacetophenone; 3'-Aminoacetophenone; 1-Amino-4-bromo-2-methylanthraquinone; 1,4-Bis[1-anthraquinonylamino]anthra- quinone; 1,4-Dimesidinoanthraquinone; 4-Dimethylaminobenzaldehyde; and Iminodianthraquinone | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¡é/kg + 39% |
| 2922.49.05 | 00 | ¡é/- α-Aminobenzeneacetic acid; 2-Amino-3-chlorobenzoic acid, methyl ester | kg | Free | | 15.4¡é/kg + 50% |
| 2922.49.40 | 20 | Glycine (Aminoacetic acid) | kg | | | |
| 2922.49.60 | 00 | 3-Aminocrotonic acid, methyl ester; and ¡é/- α-Amino-1,4-cyclohexadiene-1- acetic acid | kg | Free | | 25% |
| 2922.50.07 | 00 | 3,4-Diaminophenetole dihydrogen sulfate; 2-Nitro-5-[(2,3-dihydroxy)propoxy]-¡é/methylaniline; 2-Nitro-5-(2-hydroxyethoxy)-N-methylaniline; 4-(2-Hydroethoxy)-1,3-phenylenediamine dihydrochloride; 3-Methoxy-4-[(2-hydroxyethyl)amino]nitro- benzene; 4-[(2-Hydroxyethyl)amino]-3-nitrophenol; and ¡é/- α-Amino-4-hydroxybenzeneacetic acid (d(-)-p-Hydroxyphenylglycine) | kg | Free | | 15.4¡é/kg + 50% |
| 2922.50.11 | 00 | Salts of d(-)-p-Hydroxyphenylglycine (¡é/- α-Amino-4-hydroxybenzeneacetic acid) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 3.1% (SG) | 15.4¡é/kg + 50% |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¡é/kg + 30% |
